Stocktoria
NEKTAR THERAPEUTICS NKTR
NEKTAR THERAPEUTICS statistics & valuation
Market cap$2.2B
P / S38.9×
P / B23.9×
Net margin-297.1%
Return on equity-182.6%
FCF margin-377.8%
Return on capital-61.8%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -253.7% | -106.9% | -292.6% | -408.6% | -437.8% | -278.0% | -383.9% | 57.6% | -19.4% | -68.2% |
| Net margin | -297.1% | -120.9% | -306.3% | -400.0% | -514.0% | -290.6% | -384.5% | 57.1% | -31.4% | -92.8% |
| FCF margin | -377.8% | -180.0% | -214.7% | -336.4% | -419.6% | -209.6% | -309.7% | 59.0% | -29.3% | -74.6% |
| Return on assets | -58.5% | -39.2% | -69.4% | -51.8% | -46.9% | -28.9% | -22.3% | 31.7% | -19.0% | -27.0% |
| Return on equity | -182.6% | -195.9% | -210.8% | -100.4% | -77.1% | -41.3% | -31.4% | 39.7% | -110.1% | -174.2% |
| Current ratio | 4.97 | 4.26 | 6.45 | 8.00 | 9.34 | 9.83 | 4.02 | 17.53 | 5.82 | 5.90 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.